We analyzed data on T-cell counts (CD3 + , CD4 + , CD8 + , CD56 + /CD3 − , CD56 + /CD3 + cell populations) at COVID-19 diagnosis but did not find noteworthy correlation with any of the observed outcomes in this study. This evidence concerns the gene CD4 and COVID-19.